| 2011-02 |
Phase II study of weekly low-dose everolimus plus weekly 24-hour infusions of cisplatin and high-dose 5-fluorouracil and leucovorin for first-line treatment in patients with advanced gastric cancers |
Journal of Clinical Oncology. 2011 Feb;29(4):Abstract Number 86. |
|
| 2011-02 |
Randomized phase II study of PEP02, irinotecan, or docetaxel as a second-line therapy in gastric or gastroesophageal junction adenocarcinoma |
Journal of Clinical Oncology. 2011 Feb;29(Suppl. 4 ):Abstract Number 6 |
|
| 2010-11 |
Medical resources utilization of five most prevalent cancers in Taiwan (lung cancer, liver cancer, colorectal cancer, gastric cancer, and brest cancer): 2001 similar to 2007 |
Value in Health. 2010 Nov;13(7):A279. |
 |
| 2010-10 |
A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer |
British Journal of Cancer. 2010 Oct;103(9):1343-1348. |
|
| 2010-10 |
Combined modalities of resistance in a cisplatin-driven human betel-associated oral squamous cell carcinoma |
Annals of Oncology. 2010 Oct;21(Suppl. 8):52. |
|
| 2010-10 |
Nilotinib and sorafenib are more potent inhibitors for exon 11/17 C-kit mutants than sunitinib: results of incorporating cell-based screening platform and virtual molecular modeling study |
Annals of Oncology. 2010 Oct;21(Suppl. 8):56-56. |
|
| 2010-09 |
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients |
British Journal of Cancer. 2010 Sep;103(7):954-960. |
|
| 2010-06 |
Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma |
Annals of Oncology. 2010 Jun;21(Suppl. 6):27. |
|
| 2010-05 |
Chamaecypanone C, a novel skeleton microtubule inhibitor, with anticancer activity by trigger caspase 8-Fas/FasL dependent apoptotic pathway in human cancer cells |
Biochemical Pharmacology. 2010 May;79(9):1261-1271. |
|
| 2010-05 |
Phase I study of liposome irinotecan (PEP02) in combination with weekly infusion of 5-FU/LV in advanced solid tumors |
Journal of Clinical Oncology. 2010 May;28(15):Abstract Number e13024. |
|
| 2010-04 |
Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphoma |
Annals of Hematology. 2010 Apr;89(4):431-436. |
|
| 2010 |
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach |
Journal of Hepatology. 2010;52(6):889-894. |
|
| 2009-12 |
A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma |
Cancer Chemotherapy and Pharmacology. 2009 Dec;65(1):151-157. |
|
| 2009-12 |
Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent |
Journal of Clinical Oncology. 2009 Dec;27(36):e271. |
|
| 2009-11 |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer |
Cancer Chemotherapy and Pharmacology. 2009 Nov;64(6):1173-1179. |
|
| 2009-11 |
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009 |
Lancet Oncology. 2009 Nov;10(11):1111-1118. |
|
| 2009-10 |
Pharmacoeconomic analysis of capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX) in the first line treatment of metastasis colorectal cancer in Taiwan |
Value in Health. 2009 Oct;12(7):A278. |
|
| 2009-09 |
Synergistic augmentation of arsenic trioxide-induced cytotoxicity by BCNU through reactive oxygen species-related autophagic pathway in human solid tumors |
EJC Supplements. 2009 Sep;7(3):16. |
|
| 2009-07 |
The mechanism of the actions of oxaliplatin on ion currents and action potentials in differentiated NG108-15 neuronal cells |
NeuroToxicology. 2009 Jul;30(4):677-685. |
|
| 2009-05-20 |
Differential response of primary or secondary exon 13/14 and exon 17 c-kit mutant to nilotinib and sunitinib: Findings from a cell-based drug-screening platform |
Journal of Clinical Oncology. 2009 May 20;27(15):Abstract number e15636. |
|
| 2009-05-20 |
A phase II study of gemcitabine-based chemoradiotherapy (CCRT) after triplet induction chemotherapy (ICT) for locally advanced pancreatic cancer (LAPC): A Taiwan Cooperative Oncology Group (TCOG) study |
Journal of Clinical Oncology. 2009 May 20;27(15):Abstract number e15562. |
|
| 2009-05-20 |
Helicobacter pylori-independent MALT lymphoma patients responsive to thalidomide-the molecular mechanism and the clinical application |
Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number e19512. |
|
| 2009-05-20 |
Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC) |
Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number 4587. |
|
| 2009-05 |
RAD001 (everolimus) suppresses growth of a gastric MALT lymphoma cell Line via downregulation of pAKT/mTOR and BAFF/NF-\#954;B signal transduction pathways |
Cancer Research. 2009 May;69:Abstract number 2762. |
|
| 2009-04-17 |
Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents |
ChemMedChem. 2009 Apr 17;4(4):588-593. |
|
| 2009 |
Adjuvant interferon therpay after curative therapy for hepatocellular carcinoma (HCC): A meta-analysis |
Annals of Oncology. 2009;20(Suppl. 7):91. |
|
| 2008-12 |
Medical resource utilizations and economic burden in Chinese cancer patients with chemotherapy-induced anemia: A populational database study |
Chinese Journal of Cancer Research. 2008 Dec;20(4):307-315. |
|
| 2008-10 |
Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma |
Blood. 2008 Oct;112(7):2927-2934. |
|
| 2008-09 |
Unusual presentation of metastatic hepatocellular carcinoma in the nasal septum: A case report and review of the literature |
Medical Oncology. 2008 Sep;25(3):264-268. |
|
| 2008-08 |
Transcriptional repression of O-6-methylguanine DNA methyltransferase gene rendering cells hypersensitive to N,N '-bis(2-chloroethyl)-N-nitrosurea in camptothecin-resistant cells |
Molecular Pharmacology. 2008 Aug;74(2):517-526. |
|
| 2008-06 |
Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors |
Medical Oncology. 2008 Jun;25(2):207-213. |
|
| 2008-05 |
Cost-minimization analysis of capecitabine for advanced gastric cancer in Taiwan |
Value in Health. 2008 May-Jun;11(3):A64-A65. |
|
| 2008-05 |
Pharmacoeconomic analysis of capecitabine for advanced gastric cancer in Taiwan |
Journal of Clinical Oncology. 2008 May;26(15):Abstract number 15576. |
|
| 2008-05 |
Phase I/II study of capecitabine and PHY906 in hepatocellular carcinoma |
Journal of Clinical Oncology. 2008 May;26(15 Suppl):Abstract number 4610. |
|
| 2008-02 |
Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma - Need for a revisit of surgical treatment |
Annals of Surgery. 2008 Feb;247(2):265-269. |
|
| 2008 |
Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis |
Scandinavian Journal of Gastroenterology. 2008;43(8):992-999. |
|
| 2008 |
Expression of the nuclear factor kappa B (NFKB) P50/P65 proteins in hepatocellular carcinoma (HCC): Lack of predictive value for response to thalidomide treatment |
Journal of Hepatology. 2008;48(Suppl. 2):S145-S146. |
|
| 2008 |
PDGFRA one nucleotide deletion: A novel mutation of systemic mastocytosis associated with chronic myelomonocytic leukemia |
American Journal of Case Reports. 2008;9:10-14. |
|
| 2007-09 |
A phase II trial of oxaliplatin with high-dose of 5-fluorouracil and leucovorin in the first-line treatment of inoperable, locally advanced or metastatic biliary tract cancer |
EJC Supplements. 2007 Sep;5(4):268. |
|
| 2007-07-31 |
Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil |
British Journal of Cancer. 2007 Jul;97(3):334-344. |
|
| 2007-06 |
H pylori-positive gastric diffuse large B-cell lymphomas are potentially curable by H pylori eradication therapy |
Journal of Clinical Oncology. 2007 Jun;25(18, Suppl.):Meeting Abstract 8093. |
|
| 2007-05 |
Pharmacoeconomic analysis of capecitabine in adjuvant treatment of stage III colon cancer in Taiwan |
Value in Health. 2007 May-Jun;10(3):A11-A12. |
|
| 2007-02 |
Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - significance of tumour cell clonality and BCL10 expression |
Journal of Pathology. 2007 Feb;211(3):296-304. |
|
| 2006-12 |
Low dose of thalidomide can be effective in advanced hepatocellular carcinoma |
Journal of Gastroenterology and Hepatology. 2006 Dec;21(12):1868-1869. |
|
| 2006-11 |
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma |
Cancer Chemotherapy and Pharmacology. 2006 Nov;58(5):654-664. |
|
| 2006-11 |
Combined modalities of resistance in an oxaliplaitin-resistant human gastric cancer cell line with enhanced sensitivity |
EJC Supplements. 2006 Nov;4(12):59. |
|
| 2006-09 |
Functional polymorphisms of CD14 and toll-like receptor 4 in Taiwanese Chinese with Helicobacter pylori-related gastric malignancies |
Hepato-Gastroenterology. 2006 Sep-Oct;53(71):807-810. |
|
| 2006-07-20 |
Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma |
Journal of Clinical Oncology. 2006 Jul;24(21):3483-3489. |
|
| 2006-07-17 |
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer |
British Journal of Cancer. 2006 Jul;95(2):159-163. |
|
| 2006-05 |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer |
Journal of Gastroenterology and Hepatology. 2006 May;21(5):874-879. |
|
